Portland Global Advisors’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-67,523
| Closed | -$2.15M | – | 141 |
|
|
2025
Q1 | $2.15M | Buy |
67,523
+276
| +0.4% | +$8.78K | 0.27% | 53 |
|
|
2024
Q4 | $2.61M | Buy |
67,247
+2,343
| +4% | +$91K | 0.33% | 50 |
|
|
2024
Q3 | $2.92M | Buy |
64,904
+1,625
| +3% | +$73.1K | 0.37% | 51 |
|
|
2024
Q2 | $2.64M | Buy |
63,279
+2,756
| +5% | +$115K | 0.36% | 51 |
|
|
2024
Q1 | $2.75M | Buy |
60,523
+363
| +0.6% | +$16.5K | 0.38% | 47 |
|
|
2023
Q4 | $2.78M | Buy |
60,160
+1,948
| +3% | +$90.1K | 0.42% | 48 |
|
|
2023
Q3 | $2.37M | Buy |
58,212
+181
| +0.3% | +$7.36K | 0.4% | 51 |
|
|
2023
Q2 | $2.81M | Buy |
58,031
+1,200
| +2% | +$58.2K | 0.46% | 49 |
|
|
2023
Q1 | $2.8M | Buy |
56,831
+2,798
| +5% | +$138K | 0.48% | 52 |
|
|
2022
Q4 | $2.73M | Buy |
54,033
+1,273
| +2% | +$64.4K | 0.5% | 51 |
|
|
2022
Q3 | $2.65M | Buy |
52,760
+2,981
| +6% | +$150K | 0.53% | 49 |
|
|
2022
Q2 | $2.43M | Buy |
+49,779
| New | +$2.43M | 0.47% | 53 |
|